- Location
CKD patients
"-
Kidney Health Preserved by Consuming More Fruits and Vegetables
Dec 16, 2013Controlling dietary acid intake by increasing consumption of fruits and vegetables could help improve kidney health, according to three new studies from the US and Japan. The studies were presented at the ASN Kidney Week 2013 held at the ...
Tags: Agriculture, Food
-
The US FDA Has Approved Vifor Pharma's Hyperphosphatemia Drug Velphoro
Dec 3, 2013The US Food and Drug Administration (FDA) has approved Vifor Pharma's hyperphosphatemia drug Velphoro for the control of serum phosphorus levels in patients with Chronic Kidney Disease (CKD) on dialysis. Approval of Velphor, which is an ...
Tags: Drug, phosphate binder
-
Takeda Has Entered Into a Deal with US-Based DSI Renal for Supply of Its OMONTYS Injection
Jan 10, 2013Takeda Pharmaceuticals has entered into a deal with US-based DSI Renal for the supply of its OMONTYS (peginesatide) injection, designed for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis. ...
Tags: OMONTYS injection, anemia, chronic kidney disease, CKD patients
-
Japan Tobacco Has Filed a New Drug Application for The Marketing Approval
Jan 9, 2013Japan Tobacco (JT), Keryx Biopharmaceuticals' Japanese partner, has filed a new drug application (NDA) for the marketing approval of Ferric Citrate (Zerenex) in Japan for the treatment of hyperphosphatemia in chronic kidney disease (CKD) ...
Tags: Ferric Citrate, Tobacco, CKD, Pharmaceutical
-
The European Commission Has Granted Marketing Authorization
Nov 28, 2012The European Commission has granted marketing authorization for AMAG Pharmaceuticals' intravenous iron therapy, ferumoxytol, to treat iron deficiency anemia (IDA) in chronic kidney disease (CKD) patients. The marketing authorization is ...
Tags: AMAG Pharmaceuticals, Intravenous Iron Therapy, chronic kidney disease
-
Rockwell Received a Patent for SFP Formulation for Iron-Delivery in Hemodialysis Patients
Aug 29, 2012Rockwell Medical, a fully-integrated biopharmaceutical company, has received a new patent for Soluble Ferric Pyrophosphate (SFP) formulation for iron-delivery in hemodialysis patients from the Canadian Intellectual Property Office. ...
-
The Availability of Omontys Injection to Treat Anemia
Jun 20, 2012Affymax and Takeda Pharmaceutical Company have announced the availability of OMONTYS (peginesatide) injection to treat anemia due to chronic kidney disease (CKD) in adult patients on dialysis. The once-monthly erythropoiesis-stimulating ...
-
CMS Granted a Unique Product Reimbursement Code for Affymax's Omontys Injection
Jun 16, 2012The Centers for Medicare and Medicaid Services (CMS) has granted a unique product reimbursement code (Q-code) for Affymax's Omontys (peginesatide) injection. Omontys is a once-monthly erythropoiesis-stimulating agent (ESA) for anemia ...
Tags: omontys, peginesatide, CKD
